Surveillance after curative treatment for colorectal cancer

EP van der Stok, MCW Spaander… - Nature reviews Clinical …, 2017 - nature.com
Treatments for colorectal cancer (CRC) of all stages have evolved considerably over the
past two decades, resulting in improved long-term outcomes. After curative treatment …

Follow‐up strategies for patients treated for non‐metastatic colorectal cancer

M Jeffery, BE Hickey, PN Hider - Cochrane Database of …, 2019 - cochranelibrary.com
Follow‐up strategies for patients treated for non‐metastatic colorectal cancer - Jeffery, M - 2019
| Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Positron emission tomography (PET) in oncology

A Gallamini, C Zwarthoed, A Borra - Cancers, 2014 - mdpi.com
Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …

S3-leitlinie–kolorektales karzinom

W Schmiegel, B Buchberger… - Zeitschrift für …, 2017 - thieme-connect.com
2.1 Geltungsbereich und Zweck 2.1. 1. Zielsetzung und Fragestellung Das Kolorektale
Karzinom (KRK) ist mit etwa 64 000 Neuerkrankungen und ca. 26 000 Todesfällen pro Jahr …

Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors

BL Høeg, PE Bidstrup, RV Karlsen… - Cochrane Database …, 2019 - cochranelibrary.com
Background Most cancer survivors receive follow‐up care after completion of treatment with
the primary aim of detecting recurrence. Traditional follow‐up consisting of fixed visits to a …

American Society of Clinical Oncology 2013 top five list in oncology

LE Schnipper, GH Lyman, DW Blayney… - Journal of Clinical …, 2013 - ascopubs.org
The rising cost of health care continues to threaten the long-term vigor of the US economy.
Cancer care, although a relatively small fraction of total US health care expenditures, is …

PET/CT in oncology: current status and perspectives

J Czernin, M Allen-Auerbach, D Nathanson… - Current radiology …, 2013 - Springer
The discovery of the Warburg effect in the early twentieth century followed by the
development of the fluorinated glucose analogue 18 F-fluorodeoxyglucose (18 F-FDG) and …

NCCN task force: clinical utility of PET in a variety of tumor types

DA Podoloff, DW Ball, E Ben-Josef, AB Benson… - Journal of the National …, 2009 - jnccn.org
Use of PET is widespread and increasing in the United States, mainly for oncologic
applications. In November 2006, the National Comprehensive Cancer Network (NCCN) …

Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT

C Sperti, C Pasquali, S Bissoli, F Chierichetti… - Journal of …, 2010 - Elsevier
Introduction Pancreatic cancer recurrence is often difficult to detect by conventional imaging.
Our aim was to evaluate the impact of fluorodeoxyglucose-positron emission tomography …

Incidence and treatment of local site recurrences following RFA of colorectal liver metastases

K Nielsen, AAJM van Tilborg, MR Meijerink… - World journal of …, 2013 - Springer
Background Patients with colorectal liver metastases (CRLM) who are ineligible for curative
surgery are potential candidates for radiofrequency ablation (RFA). Although RFA has …